| BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma J Bhadury, LM Nilsson, S Veppil Muralidharan, LC Green, Z Li, ... Proceedings of the National Academy of Sciences 111 (26), E2721-E2730, 2014 | 253 | 2014 |
| Therapeutic implications for the induced levels of Chk1 in Myc-expressing cancer cells A Höglund, LM Nilsson, SV Muralidharan, LA Hasvold, P Merta, ... Clinical Cancer Research 17 (22), 7067-7079, 2011 | 147 | 2011 |
| BRAFV600 inhibition alters the microRNA cargo in the vesicular secretome of malignant melanoma cells TR Lunavat, L Cheng, BO Einarsdottir, R Olofsson Bagge, ... Proceedings of the National Academy of Sciences 114 (29), E5930-E5939, 2017 | 127 | 2017 |
| BET bromodomain inhibitors synergize with ATR inhibitors to induce DNA damage, apoptosis, senescence-associated secretory pathway and ER stress in Myc-induced lymphoma cells SV Muralidharan, J Bhadury, LM Nilsson, LC Green, KG McLure, ... Oncogene 35 (36), 4689-4697, 2016 | 61 | 2016 |
| Subcellular Distribution of p53 by the p53-Responsive lncRNA NBAT1 Determines Chemotherapeutic Response in Neuroblastoma S Mitra, SV Muralidharan, M Di Marco, PK Juvvuna, ST Kosalai, S Reischl, ... Cancer research 81 (6), 1457-1471, 2021 | 30 | 2021 |
| Aberrant Fat Metabolism in Caenorhabditis elegans Mutants with Defects in the Defecation Motor Program M Sheng, A Hosseinzadeh, SV Muralidharan, R Gaur, E Selstam, S Tuck PLoS One 10 (4), e0124515, 2015 | 21 | 2015 |
| BET bromodomain inhibitors synergize with ATR inhibitors in melanoma SV Muralidharan, BO Einarsdottir, J Bhadury, MF Lindberg, J Wu, ... Cell death & disease 8 (8), e2982-e2982, 2017 | 20 | 2017 |
| Cancer differentiating agent hexamethylene bisacetamide inhibits BET bromodomain proteins LM Nilsson, LC Green, SV Muralidharan, D Demir, M Welin, J Bhadury, ... Cancer Research 76 (8), 2376-2383, 2016 | 15 | 2016 |
| Identification of tumorigenic and therapeutically actionable mutations in transplantable mouse tumor cells by exome sequencing J Bhadury, MD Lopez, SV Muralidharan, LM Nilsson, JA Nilsson Oncogenesis 2 (4), e44-e44, 2013 | 15 | 2013 |
| Small molecule inhibitors and a kinase-dead expressing mouse model demonstrate that the kinase activity of Chk1 is essential for mouse embryos and cancer cells SV Muralidharan, LM Nilsson, MF Lindberg, JA Nilsson Life science alliance 3 (8), 2020 | 6 | 2020 |
| BET bromodomain inhibitors abrogate cell cycle progression and induces apoptosis in Myc-induced mouse lymphoma cells without affecting MYC transcription J Bhadury, LM Nilsson, L Green, Z Li, EM Gesner, SV Muralidharan, ... Cancer Research 74 (19), 2014 | 1 | 2014 |
| Targeting Myc-driven tumours-BETing on ATR S Veppil Muralidharan | | 2016 |
| Targeting Myc-driven tumours SV Muralidharan | | 2016 |
| Effects of BET bromodomain inhibitors on replication and cell cycle progression SV Muralidharan, J Bhadury, L Green, LM Nilsson, KG McLure, ... MOLECULAR CANCER RESEARCH 13, 2015 | | 2015 |
| Abstract B44: Effects of BET bromodomain inhibitors on replication and cell cycle progression SV Muralidharan, J Bhadury, L Green, LM Nilsson, KG McLure, ... Molecular Cancer Therapeutics 13 (10_Supplement), B44-B44, 2015 | | 2015 |
| Aberrant fat metabolism in Caenorhabditis elegans mutants with defects in the defecation motor program. SM Sheng Ming, A Hosseinzadeh, SV Muralidharan, R Gaur, E Selstam, ... | | 2015 |
| BET BROMODOMAIN INHIBITORS AFFECT REPLICATION & CELL CYCLE PROGRESSION SV Muralidharan, J Bhadury, L Green, LM Nilsson, KG Mclure, JA Nilsson Cancer Research 74 (19), 2014 | | 2014 |
